The treatment of uveal melanoma cells with the agonist LNS8801 also induced the expression of melanin and differentiation markers such as MITF, which directs transcription of melanocyte specific genes required for melanin synthesis, and the downstream effector TYR. This evidence concerns the gene MITF and uveal melanoma.